EUVIMEDEUVIMED entdecken
Crossref

Ammonium polyoxomolybdate modulates antibiotic activity against resistant Staphylococcus aureus and Escherichia coli

Júlio César Silva, Vitória Beatriz Roberto Silva, Luís Pereira-de-Morais, Raimundo Luiz Silva Pereira, Isaac Moura Araújo, Thiago Mielle Brito Ferreira Oliveira, Cícera Datiane de Morais Oliveira-Tintino, João Arthur de Oliveira Borges, Nair Silva Macedo, Henrique Douglas Melo Coutinho iD, Francisco Nascimento Pereira Junior iD

FEMS Microbiology Letters · 07.01.2026 · 373

DOI: 10.1093/femsle/fnag038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEMS Microbiology Letters, online erschienen am 06.04.2026. Verfasst von Júlio César Silva und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Microbiology and Molecular Biology, Department of Chemical Biology, Regional University of Cariri, Crato, 63105-000, Ceara, Brazil. Hauptthemen laut MEDLINE: Staphylococcus aureus, Escherichia coli, Anti-Bacterial Agents, Molybdenum. Die Arbeit nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigated the antibacterial and potentiating activity of ammonium polyoxomolybdate tetrahydrate (NHMO; (NH4)6Mo7O24·4H2O; 1235.86 g/mol), particularly in combination with ampicillin against Staphylococcus aureus and Escherichia coli strains. Spectroscopic characterization by attenuated total reflectance Fourier transform infrared spectroscopy and microdilution tests with resazurin were used. NHMO showed no direct antibacterial activity, with a minimum inhibitory concentration (MIC) ≥1024 μg/mL (≈0.83 mM). However, when used at a subinhibitory concentration (MIC/8, 128 μg/mL; ≈0.10 mM) with antibiotics initially tested at 1024 μg/mL, NHMO reduced the MIC of ampicillin by ~50% for both bacterial strains. Sulbactam, a known β-lactamase inhibitor, showed superior results, confirming the presence of enzymatic resistance. NHMO also demonstrated a resistance-reversal effect in β-lactamase-producing S. aureus strains, lowering the MIC of ampicillin from 20.16 to 16 μg/mL in K4100 and from 322.54 to 256 μg/mL in K4414. Ciprofloxacin did not show relevant modulation, whereas gentamicin potentiation was observed against S. aureus 10. These findings indicate that NHMO can enhance the activity of antibiotics, particularly ampicillin and gentamicin, in resistant bacterial strains. Its action in β-lactamase-related assays suggests that it is a promising candidate in the search for alternatives to combat antimicrobial resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Staphylococcus aureusEscherichia coliAnti-Bacterial AgentsMolybdenumMicrobial Sensitivity TestsAmpicillinDrug Resistance, BacterialDrug SynergismSulbactam

Stichwörter der Autor:innen

ammonium polyoxomolybdateantimicrobial resistancepolyoxometalatesβ-lactamase

Substanzen

Anti-Bacterial AgentsMolybdenumAmpicillinammonium molybdateSulbactam

Autor:innen und Institutionen

  • Laboratory of Microbiology and Molecular Biology, Department of Chemical Biology, Regional University of Cariri, Crato, 63105-000, Ceara, Brazil.
  • Physiopharmacology of Excitability Cell Laboratory, Department of Chemical Biology, Regional University of Cariri, Crato, 63105-000, Ceará, Brazil.
  • Chemistry Laboratory, The Federal University of Cariri, Juazeiro do Norte, 63048-080, Ceara, Brazil.

ORCID-Profile: Henrique Douglas Melo Coutinho, Francisco Nascimento Pereira Junior

Zitieren

APA

Silva, J. C., Silva, V. B. R., Pereira-de-Morais, L., Pereira, R. L. S., Araújo, I. M., Oliveira, T. M. B. F., Oliveira-Tintino, C. D. M., Borges, J. A. O., Macedo, N. S., Coutinho, H. D. M., & Pereira Junior, F. N. (2026). Ammonium polyoxomolybdate modulates antibiotic activity against resistant Staphylococcus aureus and Escherichia coli. FEMS Microbiology Letters, 373. https://doi.org/10.1093/femsle/fnag038

Vancouver

Silva JC, Silva VBR, Pereira-de-Morais L, Pereira RLS, Araújo IM, Oliveira TMBF, et al. Ammonium polyoxomolybdate modulates antibiotic activity against resistant Staphylococcus aureus and Escherichia coli. FEMS Microbiology Letters. 2026;373. doi:10.1093/femsle/fnag038

BibTeX
@article{Silva2026,
  author = {Silva, Júlio César and Silva, Vitória Beatriz Roberto and Pereira-de-Morais, Luís and Pereira, Raimundo Luiz Silva and Araújo, Isaac Moura and Oliveira, Thiago Mielle Brito Ferreira and Oliveira-Tintino, Cícera Datiane de Morais and Borges, João Arthur de Oliveira and Macedo, Nair Silva and Coutinho, Henrique Douglas Melo and Pereira Junior, Francisco Nascimento},
  title = {Ammonium polyoxomolybdate modulates antibiotic activity against resistant Staphylococcus aureus and Escherichia coli},
  journal = {FEMS Microbiology Letters},
  year = {2026},
  volume = {373},
  doi = {10.1093/femsle/fnag038}
}
Kostenlos starten →